Madhavbaug

Thane, India Founded: 2014 • Age: 12 yrs Listed

A chain of cardiac care hospitals and clinics is operated.

Page last updated 19 Oct 2026

About Madhavbaug

Madhavbaug is a publicly listed company based in Thane (India) founded in 2014 by Rohit Sane. It operates as an a chain of cardiac care hospitals and clinics is operated. The company has 491 employees. Its chief executive is Rohit Sane. Its website madhavbaug.org draws about 84 thousand monthly visits. Its Indian entity Vaidya Sane Ayurved Laboratories Limited reported revenue of ₹109 Cr. Madhavbaug offers products and services including mibPULSE App, Ayurvedic Treatments, and Diet and Lifestyle Programs. Its focus areas include Hospital Chains, Single Specialty Hospital Chains and Cardiology. Its competitors include Maple Hospital and Kant Multispeciality Hospital.

Company details

Madhavbaug was established in 2014 in Thane, India, by Rohit Sane as founder and CEO. Cardiac care services are delivered through a network of hospitals and clinics in the healthcare sector. Operations focus on heart disease management and preventive treatments. The company is headquartered in Thane, with presence extended across multiple locations in India to serve patients requiring specialized cardiac interventions.

Headquarters Thane, India
Employees 491
Founders Rohit Sane
Stage Public
Sectors
Healthcare
Website category Health · Alternative and Natural Medicine
Email
••••••••
Phone
•••• ••••
Website madhavbaug.org
Social LinkedIn X Facebook YouTube
Legal Name Vaidya Sane Ayurved Laboratories Limited

Operational Areas

Healthcare → Hospitals & Clinical Care

Key Metrics

Market Cap
₹165 Cr
MADHAVBAUG-ST · NSE
Revenue
₹107 Cr
FY 2025-26 · +19.0% YoY
EBITDA
₹15.42 Cr
Margin 14.4%
Net Profit
₹9.00 Cr
FY 2025-26 · +12.1% YoY
P/E (TTM)
18.9x
P/B 1.9x
Employee Count
491

Associated legal entities of Madhavbaug

Madhavbaug operates through Vaidya Sane Ayurved Laboratories Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.

Legal entity	Status	Incorporated	Registered in	Revenue (FY 2026)	Employees	Directors	Company page
Vaidya Sane Ayurved Laboratories Limited Listed CIN L73100PN1999PLC013509	Active	06 Apr 1999	Pune City, Maharashtra	₹109 Cr	491	8	View details

Products & Services of Madhavbaug

Madhavbaug offers a comprehensive portfolio of products and services, including mibPULSE App, Ayurvedic Treatments, and Diet and Lifestyle Programs.

mibPULSE App

Health Monitoring

Mobile app for tracking heart disease and health metrics

Ayurvedic Treatments

Therapy

Non-surgical solutions for heart and diabetes conditions

Diet and Lifestyle Programs

Wellness Services

Personalized plans for managing obesity and hypertension

Apps and channels of Madhavbaug

Madhavbaug publishes 1 mobile app with over 100K+ downloads; its YouTube channel Madhavbaug has 39.4K subscribers and 30 videos.

mibPULSE

Google Play Education Everyone Free 100K+ downloads

Developer: Madhavbaug

View on Google Play

Madhavbaug

YouTube 39.4K subscribers 30 videos People & Blogs

Open channel

Videos from Madhavbaug

The most watched videos on Madhavbaug's YouTube channel, Madhavbaug (39.4K subscribers). Click a video to play it here.

Bharat Pawar’s Heart Blockage Recovery – Now Walking 15 Minutes Daily After Madhavbaug Treatment!

5.6K views

Neha Seth's Panchakarma Experience at Madhavbaug Khopoli | Stress & Anxiety Relief

1.5K views

Health ki Gharwapsi | Madhavbaug - Advansed Ayurveda Clinics and Hospital | Sonu Sood #madhavbaug

1.5K views

Hasmat Sheikh’s Panchakarma Journey at Madhavbaug Khopoli – Recommended by His Son!

1.2K views

Board of directors of Vaidya Sane Ayurved Laboratories Limited (Madhavbaug)

Vaidya Sane Ayurved Laboratories Limited is the primary company behind Madhavbaug. The board of Vaidya Sane Ayurved Laboratories Limited currently have 5 directors; the longest-serving is Rohit Madhav Sane, appointed in 2005. 10 earlier directors have ceased.

Director	Designation	Appointed	Tenure	Entity
Rohit Madhav Sane DIN 00679851	Managing Director	01 Mar 2005	21 yrs 7 mo	Vaidya Sane Ayurved Laboratories Limited
Ratnakar Venkappa Rai DIN 00126309	Director	01 Sep 2021	5 yrs 1 mo	Vaidya Sane Ayurved Laboratories Limited
Vidyut Bipin Ghag DIN 09299252	Whole-time director	01 Sep 2021	5 yrs 1 mo	Vaidya Sane Ayurved Laboratories Limited
Sushrut Raghavendra Dambal DIN 06795550	Director	01 Nov 2021	4 yrs 11 mo	Vaidya Sane Ayurved Laboratories Limited
Mahesh Pandurangrao Kshirsagar DIN 07612577	Director	01 Nov 2021	4 yrs 11 mo	Vaidya Sane Ayurved Laboratories Limited

People of Madhavbaug

2 people are tracked at Madhavbaug (1 in leadership, 1 in team); the tracked headcount is 491.

Name	Role	Group
Rohit Sane	Founder & CEO	Leadership
Saurabh Kulkarni	Franchise Development Manager	Team

Premium access

Complete people profiles for Madhavbaug

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

Full employee list
Team structure
Board tenure
Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Madhavbaug

Madhavbaug is a publicly listed company on the NSE with ticker symbol MADHAVBAUG in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

IPO date23 Feb 2022
Listed onNSE: MADHAVBAUG
Listed entityVaidya Sane Ayurved Laboratories Limited
Exchange sectorHealth services
ISININE0JR301013
Share price₹168.15 (-1.09% on the day) · 2026-10-14
Market capitalisation₹186 Cr
Price to earnings19.7
EPS (diluted, trailing year)₹8.55
Volume (last session)2,000

Financials of Madhavbaug

Exchange-reported figures of Vaidya Sane Ayurved Laboratories Limited, the listed company behind Madhavbaug (NSE: MADHAVBAUG-ST).

Financial Highlights

FY 2025-26 · Consolidated

Revenue

₹107 Cr

+19.0% YoY

EBITDA

₹15.42 Cr

+25.4% YoY

Profit After Tax

₹9.00 Cr

+12.1% YoY

Net Worth

Total Assets

Total Debt

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Income statement
Revenue	107	89.85	99.33	99.17
Revenue growth	+19.0%	-9.5%	+0.2%	-
EBITDA	15.42	12.30	4.50	8.52
EBITDA margin	+14.4%	+13.7%	+4.5%	+8.6%
Profit before tax	10.81	9.90	2.86	6.42
Net profit	9.00	8.03	1.52	4.82
Net profit margin	+8.4%	+8.9%	+1.5%	+4.9%
EPS (₹)	8.04	6.80	1.88	4.60
Balance sheet
Total assets	-	66.90	59.77	42.14
Net worth	-	62.54	55.61	40.45
Total debt	-	1.46	1.68	0.13
Cash & bank	-	2.36	2.37	1.76
Net working capital	-	5.56	5.42	1.24
Cash flow
Cash from operations	-	10.60	(1.26)	0.06
Cash from investing	-	(10.08)	(12.99)	0.52
Cash from financing	-	(0.54)	14.86	(1.38)

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Income statement
Revenue	99.62	87.11	97.33	99.03	74.71	52.27	75.23
Revenue growth	+14.4%	-10.5%	-1.7%	+32.6%	+42.9%	-30.5%	-
EBITDA	10.32	8.94	3.24	9.02	7.32	3.30	2.92
EBITDA margin	+10.4%	+10.3%	+3.3%	+9.1%	+9.8%	+6.3%	+3.9%
Profit before tax	6.09	6.88	1.43	6.93	4.74	0.44	(0.44)
Net profit	4.94	5.77	0.76	5.21	3.46	0.91	(0.55)
Net profit margin	+5.0%	+6.6%	+0.8%	+5.3%	+4.6%	+1.7%	-0.7%
EPS (₹)	4.41	4.66	0.99	4.94	3.30	87.11	(123.82)
Balance sheet
Total assets	-	63.91	59.14	42.50	38.51	12.90	15.82
Net worth	-	59.70	55.02	40.81	35.88	9.77	8.22
Total debt	-	1.46	1.68	0.13	1.06	1.02	5.97
Cash & bank	-	2.32	2.19	1.75	2.56	0.90	1.06
Net working capital	-	2.93	2.48	2.29	(2.58)	(5.72)	(4.27)
Cash flow
Cash from operations	-	7.58	3.39	(0.43)	(13.31)	5.77	7.72
Cash from investing	-	(6.91)	(17.42)	1.00	(7.52)	(0.67)	(3.93)
Cash from financing	-	(0.54)	14.46	(1.38)	22.49	(5.26)	(3.63)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 20 Oct 2026

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Revenue	107	89.85	99.33	99.17
Revenue growth	+19.0%	-9.5%	+0.2%	-
Other income	2.37	1.86	1.75	1.36
Total expenses	91.49	77.55	94.83	90.65
Employee cost	0.00	19.65	25.77	21.40
EBITDA	15.42	12.30	4.50	8.52
EBITDA margin	+14.4%	+13.7%	+4.5%	+8.6%
Depreciation	6.13	4.16	3.14	2.60
Interest	0.85	0.10	0.25	0.86
Profit before tax	10.81	9.90	2.86	6.42
Tax	1.81	2.74	0.87	1.60
Net profit	9.00	8.03	1.52	4.82
Net profit margin	+8.4%	+8.9%	+1.5%	+4.9%
EPS (₹)	8.04	6.80	1.88	4.60

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Equity & liabilities
Share capital	-	10.52	10.52	10.51
Reserves & surplus	-	52.02	31.66	29.94
Shareholders' funds (net worth)	-	62.54	55.61	40.45
Minority interest	-	0.00	0.00	0.00
Secured loans	-	1.46	1.68	0.13
Unsecured loans	-	0.00	0.00	0.00
Total debt	-	1.46	1.68	0.13
Total liabilities	-	66.90	59.77	42.14
Assets
Gross block	-	56.37	46.77	35.42
Net block	-	33.66	28.16	20.95
Capital work in progress	-	1.26	2.47	1.67
Investments	-	21.31	17.99	15.33
Inventories	-	3.76	4.11	3.41
Sundry debtors	-	7.54	6.05	5.99
Cash & bank balances	-	2.36	2.37	1.76
Loans & advances	-	1.67	2.83	2.82
Total current assets	-	15.33	15.36	13.98
Total current liabilities	-	9.77	9.94	12.74
Net working capital	-	5.56	5.42	1.24
Total assets	-	66.90	59.77	42.14

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Opening cash	-	2.37	1.76	2.56
Net cash from operating activities	-	10.60	(1.26)	0.06
Net cash from investing activities	-	(10.08)	(12.99)	0.52
Net cash from financing activities	-	(0.54)	14.86	(1.38)
Net change in cash	-	(0.01)	0.61	(0.80)
Closing cash	-	2.36	2.37	1.76

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Growth
Sales growth	+19.0%	-9.5%	+0.2%	-
EBITDA growth	+25.4%	+173.3%	-47.2%	-
PBT growth	+9.2%	+246.2%	-55.5%	+9997.0%
Net income growth	+12.1%	+428.3%	-68.5%	-
Revenue CAGR (3Y)	+2.5%	-	-	-
EBITDA CAGR (3Y)	+21.9%	-	-	-
Profitability & leverage
Net income margin	+8.4%	+8.0%	+2.0%	+4.9%
Return on capital employed	-	+17.7%	+5.4%	+17.3%
Return on net worth	-	+13.6%	+3.2%	+11.9%
Debt / equity	-	0.03	0.02	0.00
Long-term debt / equity	-	0.00	0.00	0.00
Interest cover	9.15	1.23	18.38	14.53
Efficiency & per share
Fixed asset turnover	-	1.74	2.42	2.80
Inventory turnover	-	22.83	26.42	29.08
Debtors turnover	-	13.22	16.50	16.56
EPS (₹)	8.04	6.80	1.88	4.60
Dividend per share (₹)	0.00	0.00	0.00	0.25
Book value per share (₹)	0.00	59.44	40.10	38.48

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Revenue	99.62	87.11	97.33	99.03	74.71	52.27	75.23
Revenue growth	+14.4%	-10.5%	-1.7%	+32.6%	+42.9%	-30.5%	-
Other income	2.19	1.77	1.47	1.36	0.34	0.10	0.07
Total expenses	89.30	78.17	94.09	90.01	67.39	48.97	72.31
Employee cost	0.00	18.35	24.49	21.21	17.82	13.36	20.82
EBITDA	10.32	8.94	3.24	9.02	7.32	3.30	2.92
EBITDA margin	+10.4%	+10.3%	+3.3%	+9.1%	+9.8%	+6.3%	+3.9%
Depreciation	5.61	3.73	3.03	2.60	2.29	2.45	2.23
Interest	0.81	0.10	0.25	0.85	0.63	0.51	1.20
Profit before tax	6.09	6.88	1.43	6.93	4.74	0.44	(0.44)
Tax	1.15	1.97	0.41	1.72	1.28	0.07	0.11
Net profit	4.94	5.77	0.76	5.21	3.46	0.91	(0.55)
Net profit margin	+5.0%	+6.6%	+0.8%	+5.3%	+4.6%	+1.7%	-0.7%
EPS (₹)	4.41	4.66	0.99	4.94	3.30	87.11	(123.82)

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Equity & liabilities
Share capital	-	10.51	10.51	10.51	10.51	0.05	0.05
Reserves & surplus	-	49.19	31.08	30.30	25.37	9.72	8.17
Shareholders' funds (net worth)	-	59.70	55.02	40.81	35.88	9.77	8.22
Secured loans	-	1.46	1.68	0.13	1.06	1.02	0.00
Unsecured loans	-	0.00	0.00	0.00	0.00	0.00	5.97
Total debt	-	1.46	1.68	0.13	1.06	1.02	5.97
Total liabilities	-	63.91	59.14	42.50	38.51	12.90	15.82
Assets
Gross block	-	44.89	36.47	35.42	28.90	26.82	22.73
Net block	-	26.97	22.08	20.95	17.00	17.16	15.51
Capital work in progress	-	1.26	2.60	1.67	1.23	0.38	3.79
Investments	-	26.38	24.88	14.85	21.49	0.01	0.02
Inventories	-	2.02	3.06	3.41	1.50	1.61	2.90
Sundry debtors	-	7.03	5.84	6.46	3.56	2.64	2.50
Cash & bank balances	-	2.32	2.19	1.75	2.56	0.90	1.06
Loans & advances	-	1.29	2.94	3.40	1.25	2.04	2.04
Total current assets	-	12.66	14.03	15.02	8.87	7.19	8.50
Total current liabilities	-	9.73	11.55	12.73	11.45	12.91	12.77
Net working capital	-	2.93	2.48	2.29	(2.58)	(5.72)	(4.27)
Total assets	-	63.91	59.14	42.50	38.51	12.90	15.82

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Opening cash	-	2.19	1.75	2.56	0.90	1.06	0.90
Net cash from operating activities	-	7.58	3.39	(0.43)	(13.31)	5.77	7.72
Net cash from investing activities	-	(6.91)	(17.42)	1.00	(7.52)	(0.67)	(3.93)
Net cash from financing activities	-	(0.54)	14.46	(1.38)	22.49	(5.26)	(3.63)
Net change in cash	-	0.14	0.43	(0.81)	1.66	(0.16)	0.16
Closing cash	-	2.32	2.19	1.75	2.56	0.90	1.06

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Growth
Sales growth	+14.4%	-10.5%	-1.7%	+32.6%	+42.9%	-30.5%	-
EBITDA growth	+15.4%	+175.9%	-64.1%	+23.2%	+121.8%	+13.0%	-
PBT growth	-11.5%	+381.1%	-79.4%	+46.2%	+977.3%	+9998.0%	-
Net income growth	-14.4%	+659.2%	-85.4%	+50.6%	+280.2%	+265.5%	-
Revenue CAGR (3Y)	+0.2%	+5.3%	+23.0%	+9.6%	+6.1%	-	-
EBITDA CAGR (3Y)	+4.6%	+6.9%	-0.6%	+45.6%	+33.2%	-	-
Profitability & leverage
Net income margin	+5.0%	+5.6%	+1.1%	+5.3%	+4.6%	+0.7%	-0.7%
Return on capital employed	-	+13.3%	+3.0%	+19.2%	+20.9%	+14.8%	+4.4%
Return on net worth	-	+10.0%	+1.7%	+13.5%	+15.2%	+10.3%	-6.6%
Debt / equity	-	0.03	0.02	0.02	0.05	0.39	0.86
Long-term debt / equity	-	0.00	0.00	0.00	0.00	0.00	0.00
Interest cover	17.20	1.92	119.05	13.24	12.52	60.00	173.91
Efficiency & per share
Fixed asset turnover	-	2.14	2.71	3.08	2.68	2.11	3.45
Inventory turnover	-	34.30	30.09	40.34	48.05	23.18	23.11
Debtors turnover	-	13.54	15.83	19.77	24.10	20.34	24.47
EPS (₹)	4.41	4.66	0.99	4.94	3.30	87.11	(123.82)
Dividend per share (₹)	0.00	0.00	0.00	0.25	0.00	0.00	0.00
Book value per share (₹)	0.00	56.78	39.56	38.82	34.13	2,170.44	1,826.64

Competitors of Madhavbaug

Madhavbaug has 2 listed competitors in our database. They include Maple Hospital and Kant Multispeciality Hospital, among others.

Company Name	Domain	Founded	HQ Location	Total funding	Employees	Description
Maple Hospital	maplehospital.in	2023	Bharuch, India	–	–	Cardiac care and medical services are provided through hospital networks.
Kant Multispeciality Hospital	kantmultispecialityhospital.com	2022	Faridabad, India	–	–	A multispeciality hospital offering advanced medical and surgical treatments with the latest technology.

Premium access

Detailed competitors of Madhavbaug

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

Full competitor set
Operating metrics
Benchmarks
Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Madhavbaug

The website of Madhavbaug (madhavbaug.org) receives about 83.9K visits a month and ranks #603,682 among all websites worldwide, #531 in Alternative and Natural Medicine.

Monthly visits
83.9K
▲ 75.5% vs previous month
Unique visitors
25.8K
per month
Global rank
#603,682
among all websites
Category rank
#531
Health · Alternative and Natural Medicine

Visitor engagement

Bounce rate36%
Pages per visit2.9
Average visit1 min 39 sec
Devices
Desktop 9% · Mobile 91%

Similar websites

Websites whose visitors overlap most with Madhavbaug. Affinity shows how closely the audiences match.

Website	Domain	Audience affinity	Monthly visits	Global rank	Profile
acharyamanish.com	acharyamanish.com	100%	–	#909,332	–
ayushportal.nic.in	ayushportal.nic.in	98%	–	–	–
Sreedhareeyam	sreedhareeyam.com	96%	34.4K	#759,965	View details
Ayurprakash	ayurprakash.com	95%	6.2K	#1,971,541	View details
welcometonature.org	welcometonature.org	94%	–	–	–
••••••••••	••••••.com	••%	•.•M	#•••••	–
••••••••••	••••••.com	••%	•.•M	#•••••	–
••••••••••	••••••.com	••%	•.•M	#•••••	–

Premium access

All 38 similar websites and full traffic analytics for Madhavbaug

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

38 similar websites
Audience overlap
Engagement analytics
Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Hospitals & Clinical Care

10 companies that operate in the same segment as Madhavbaug (Hospitals & Clinical Care), ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Total funding	Revenue	Employees
Cloudnine	Maternity, childcare, and fertility services are delivered via hospital chains.	2007	Bengaluru, Karnataka, India	USD 204.87 M	USD 140.46 M	4,459
HCG	Chain of oncology hospitals	1989	Bengaluru, Karnataka, India	USD 36.59 M	USD 270.51 M	8,400
Medanta	Chain of multi-super specialty healthcare hospitals	2004	Gurugram, Haryana, India	USD 104.7 M	USD 461.72 M	12,240
KIMS Hospitals	Multispeciality secondary and tertiary care is provided by hospital chains.	1999	Secunderabad, Telangana, India	USD 62.46 M	USD 416.2 M	6,490
Max Healthcare	Multispecialty hospitals are operated as a chain in India.	2001	Delhi, Delhi, India	–	USD 889.96 M	26,830
HCA Healthcare	Multi-specialty hospitals and surgery centers are operated nationwide.	1968	Nashville, Tennessee, United States	USD 97.27 M	USD 75.6 B	316,000
Small Door	Standalone veterinary clinics are operated for pet care services.	2017	New York, New York, United States	USD 98.5 M	–	–
Ochsner	Healthcare services, research, education, and community support are provided.	1942	United States	–	–	–
Cityblock	Provider of tech-heavy clinics for multiple healthcare solutions for patients	2017	Brooklyn, New York, United States	USD 1.02 B	–	785
Manipal Hospitals	Multispecialty hospitals are operated as a chain in India.	1991	Bengaluru, Karnataka, India	USD 645.32 M	USD 1.1 B	–

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.

Included in your Premium account

✓
Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
✓
Full access to every database India & global coverage, advanced filters and rich profile details
✓
Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Madhavbaug

When was Madhavbaug founded?

Madhavbaug was founded in 2014.

Where is Madhavbaug located?

Madhavbaug is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.

Who is the current CEO of Madhavbaug?

Rohit Sane is the current CEO of Madhavbaug. They have also founded this company.

How many employees does Madhavbaug have?

Madhavbaug has 491 employees.

What is the annual revenue of Madhavbaug?

The primary company behind Madhavbaug, Vaidya Sane Ayurved Laboratories Limited, reported revenue of ₹109 Cr for FY 2026, up 19% year on year.

What does Madhavbaug do?

Who are the top competitors of Madhavbaug?

Madhavbaug's top competitors include Maple Hospital and Kant Multispeciality Hospital.

What products or services does Madhavbaug offer?

Madhavbaug offers mibPULSE App, Ayurvedic Treatments, and Diet and Lifestyle Programs.

Is Madhavbaug publicly traded?

Yes, Madhavbaug is publicly traded on NSE under the ticker symbol MADHAVBAUG.

Which legal entities are associated with Madhavbaug?

Madhavbaug operates through Vaidya Sane Ayurved Laboratories Limited.

Who are the directors of Madhavbaug?

The legal entities of Madhavbaug currently have 8 directors, including Ratnakar Venkappa Rai, Rohit Madhav Sane, Sushrut Raghavendra Dambal and others.

Does Madhavbaug have a mobile app?

Yes. Madhavbaug publishes mibPULSE, with over 100,000 downloads.

Madhavbaug

About Madhavbaug

Company details

Operational Areas of Madhavbaug

Associated legal entities of Madhavbaug

Products & Services of Madhavbaug

Apps and channels of Madhavbaug

Videos from Madhavbaug

Board of directors of Vaidya Sane Ayurved Laboratories Limited (Madhavbaug)

People of Madhavbaug

Complete people profiles for Madhavbaug

IPO & Listings of Madhavbaug

Financials of Madhavbaug

Financial Highlights

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

Financial Statements

Competitors of Madhavbaug

Detailed competitors of Madhavbaug

Web traffic of Madhavbaug

All 38 similar websites and full traffic analytics for Madhavbaug

Top companies in Hospitals & Clinical Care

Related news about Madhavbaug

Complete news archive for Madhavbaug

Frequently Asked Questions about Madhavbaug

About Madhavbaug

Company details

Operational Areas of Madhavbaug

Associated legal entities of Madhavbaug

Products & Services of Madhavbaug

Apps and channels of Madhavbaug

Videos from Madhavbaug

Board of directors of Vaidya Sane Ayurved Laboratories Limited (Madhavbaug)

People of Madhavbaug

Complete people profiles for Madhavbaug

IPO & Listings of Madhavbaug

Financials of Madhavbaug

Financial Highlights

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr Consolidated Standalone AnnualQuarterly

Financial Statements

Competitors of Madhavbaug

Detailed competitors of Madhavbaug

Web traffic of Madhavbaug

All 38 similar websites and full traffic analytics for Madhavbaug

Top companies in Hospitals & Clinical Care

Related news about Madhavbaug

Complete news archive for Madhavbaug

Frequently Asked Questions about Madhavbaug

Financial summary ₹ Cr